- TD-A Brief Overview of the More Common Indications for Lab Studies
- TD-A Modern Approach to Dry Eye
- TD-Advanced Procedures with RadioFrequency
- TD-Age Related Macular Degeneration - 2022 Update
- TD-AMD Updates: Staying Current with its Landscape
- TD-Anterior Segment Grand Rounds
- TD-Applications of Angiography (FA, ICG, OCTA)
- TD-Battle of the Omegas - Comparing Nutritional Strategies in Dry Eye Disease
- TD-Beauty Confidential
- TD-Benefits of Managing the Eyelid Margin in Meibomian Gland Dysfunction
- TD-Beyond the Posterior Pole
- TD-Caution Steep Hill Ahead: Managing Keratoconus in Clinical Practice: Are you Ready to Conquer Keratoconus?
- TD-Contemporary Diabetic Retinopathy Care
- TD-Contemporary Keratoconus
- TD-Corneal Collagen Crosslinking (CXL): MD and OD Perspective
- TD-Demodex Diaries
- TD-Eyelid Ptosis: Make the Right Diagnosis
- TD-From Retinal Findings to Systemic Diagnosis
- TD-How to Heal When You Can’t Feel – Neurotrophic Keratitis Update
- TD-Imaging the Anterior Segment
- TD-Innovations in Ocular Surface Disease to Maximize Patient Outcomes
- TD-Intravitreal Injections - What Optometry Should Know
- TD-Lids and Lashes on the Cutting Edge
- TD-Lumps and Bumps: A Practical Guide to Evaluation and Management
- TD-Minor Surgical Procedures
- TD-New Developments in Anti-VEGF Therapy
- TD-OCT Angiography Grand Rounds
- TD-On Call with Melton and Vollmer
- TD-Optometry & Genetics: The Future of Precision Medicine
- TD-Peeling Back the Layers: A Case Based Trip Around the Cornea
- TD-Retina OCT Workshop: How to Scan How to Interpret
- TD-Screening for Carcinoma of the Eyelids
- TD-Seeing White Dots
- TD-Sensitivity Training; A Chronicle of Neurotrophic Keratitis (NK) Management
- TD-Solving the Scleritis Dilemma
- TD-The Complete Course on Corneal Dystrophies and Degenerations
- TD-The Ocular Adnexa. Optometry's Next Frontier
- TD-Treatment Strategies for Refractory Ocular Surface Disease
- TD-Unraveling Intraocular Inflammation
- TD-Using IPL to address ocular surface and adnexal conditions
- TD-Worst Case Scenarios- A Co-Management Review of Ocular Trauma Emergencies from Pediatrics to Adults
TD-Panel Discussion: Is There a Treatment for Me? Genetic Testing, Clinical Trials, Gene Therapy, & Future Treatments Q&A
Description:
The recent developments in genetics research have led to an incredible growth in our understanding of ocular conditions, leading to the 2017 FDA approval of the first groundbreaking gene therapy and the ongoing development of new gene therapies for numerous inherited retinal dystrophies. Our increased understanding of the genetics of eye conditions expands the opportunities for eye care practitioners to provide patients with more specific diagnoses, more accurate assessment of prognoses, and improved counseling. This includes the ability to deliver gene-specific patient education on eligibility for gene therapy and gene therapy clinical trials. This panel presentation and discussion will provide an introductory level overview of the most common patient questions and answers surrounding genetic testing and gene therapy. We will cover the current state of gene therapy as well as other ongoing clinical trials, including developments in CRISPR gene editing, optogenetics, and antisense oligonucleotide-based therapy. Focus will be placed on covering the information optometrists can provide to patients to help them make the best informed decisions about their ocular management. We will also discuss the ramifications of gene therapy for the future of low vision rehabilitation and ocular health management. Attendees will be provided with resources to stay up-to-date with genetics information and clinical trials.
Course Code:
AOA218-TD
Speaker(s):
Rachelle Lin, O.D.
rachelle.lin@gmail.com
Ben Shaberman, O.D.
bshaberman@fightingblindness.org
Jill Dolgin, PharmD
jdolgin@agtc.com
Credits:
2
AOA Expiration Date:
3/3/2025